IFLScience on MSN19h
Revolutionary Nasal Nerve Cell "Bridges" For Treating Spinal Injuries To Begin Clinical TrialsThe unique regeneration capacity of nerve cells has been the focus of spinal injury research for decades, but a new method ...
Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum ...
Victorian women who were part of a large international breast cancer drug trial say it has been a “life saver”.
Ipsen S.A. (OTCMKTS:IPSEY – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $30.55 and ...
Christopher G. Chute and Jeffrey D. Rothstein are among 100 new members recognized for outstanding professional achievements ...
WNEM Saginaw on MSN16h
Bad Habits that Raise Your Risk for DementiaEvery three seconds, someone in the world develops dementia. Currently, there are more than 55 million people living with dementia worldwide, and that number is expected to double every 20 years. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback